Delivery Order SPE2DB22D6029-SPE2DB25FLVUV
Award Date 8/29/25
Potential Completion Date 9/2/25
Potential Value $1.2K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,461.08 to AmerisourceBergen Drug Corp on August 29, 2025, for the supply of Ropivacaine 0.2% 400 mg/200 mL in 200 mL units. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of September 2, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $3,235.22 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 mL) on August 5, 2025, with completion scheduled for August 6, 2025. This competitively awarded, firm fixed-price delivery order represents a continuation of AmerisourceBergen's pharmaceutical supply services to the federal government and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The contract...
- The Defense Logistics Agency awarded a $1,790.53 firm fixed-price delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Ropivacaine 0.2% (400 mg/200 mL vials). The contract, which is a non-set-aside competitive award with an ultimate completion date of July 28, 2025, represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. This delivery order will be fulfilled from the vendor's facility in Conshohocken,...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,646.08 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml), a local anesthetic pharmaceutical product. The contract, issued on August 11, 2025, with an ultimate completion date of August 12, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will be executed from the contractor's location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order valued at $9,685.05 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml format) with a completion date of August 26, 2025. This firm fixed-price delivery order, awarded without set-aside provisions on August 25, 2025, will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $3,342.70 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 mL vials). This firm fixed price contract, issued on August 15, 2025, represents a competitively awarded procurement with no set-aside designation and an ultimate completion date of August 18, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% in a 400 mg/200 mL concentration with a ceiling value of $1,529.13. This competitive, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. Ropivacaine is a local anesthetic used in medical and surgical procedures, and this...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of ropivacaine 0.2% 400 mg/200 ml medical products. The order has a firm fixed price of $1,749.64 and a completion date of January 28, 2025. The contract is not designated as a set-aside and is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support Medical, which...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,410.92 to AmerisourceBergen Drug Corp for the supply of Ropivacaine 0.2% (400 mg/200 ml, 200 ml units) with an ultimate completion date of August 22, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical vendor...
- This is a $2,665.10 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of 4566997560 - Ropivacaine 0.2% 400 mg/200 mL 200 mL, with a performance period running through January 22, 2025. This delivery order is placed under Amerisourcebergen's existing $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...